Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003260410 | SCV003955030 | uncertain significance | Inborn genetic diseases | 2023-06-02 | criteria provided, single submitter | clinical testing | The c.1184C>T (p.A395V) alteration is located in exon 10 (coding exon 10) of the TTC21B gene. This alteration results from a C to T substitution at nucleotide position 1184, causing the alanine (A) at amino acid position 395 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005021883 | SCV005651290 | uncertain significance | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2024-03-06 | criteria provided, single submitter | clinical testing |